Gujarat Kidney and Super Speciality has scheduled its seventh Annual General Meeting (AGM) for Monday, September 28, 2026. The meeting will commence at 9:30 am in physical mode.

The company notified the BSE and NSE on September 1, 2026, regarding the pre-advertisement notice for the gathering. This disclosure complies with Regulations 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The AGM aims to transact business as outlined in the official notice. Members whose email addresses are registered with the company, depository participants, or the Registrar and Share Transfer Agent as on Friday, August 28, 2026, will receive the notice and annual report electronically.

Shareholders who have not registered their email addresses will receive a letter containing a web link and QR code to access the annual report for FY26. This process adheres to Regulation 36(1)(b) of the SEBI Listing Regulations.

Voting Procedures

Members can cast votes through remote e-voting or via ballot paper during the meeting. Those attending physically who have not voted remotely remain eligible to vote using ballot papers.

The company encourages members holding shares in physical form to dematerialize their holdings or register their details with MUFG Intime India Private Limited. Demat holders are advised to update their contact information with respective depository participants to ensure receipt of electronic communications.

Gujarat Kidney and Super Speciality will participate in the GIA Healthcare Day on August 31, 2026, engaging with investors and analysts in Mumbai. The physical group meeting is scheduled for 10:00 am to 11:00 am at the Jio World Convention Centre in BKC.

The company issued the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Management confirmed that discussions will rely solely on publicly available documents, with no unpublished price-sensitive information intended for release.

Meeting Details

The schedule remains indicative and subject to change due to unforeseen developments. The company noted the shorter notice period resulted from recently engaging Go India Advisors as its investor relations and public relations agency.

Dr Pragnesh Bharpoda, Managing Director, signed the disclosure filed with both the Bombay Stock Exchange and the National Stock Exchange of India. Investors interested in attending can register via the provided access link.